Know Cancer

or
forgot password

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients (Old Title: Significance of CD44 and or Epithelial Specific Antigen Positive Cells in the Peripheral Blood of Lung Cancer Patients) (LUN0017)


N/A
18 Years
N/A
Open (Enrolling)
Both
Lung Cancer

Thank you

Trial Information

Identification of Circulating Tumor Cells in the Peripheral Blood of Lung Cancer Patients (Old Title: Significance of CD44 and or Epithelial Specific Antigen Positive Cells in the Peripheral Blood of Lung Cancer Patients) (LUN0017)


The purpose of this study is to determine whether we can identify lung cancer cells
circulating in the peripheral blood of lung cancer patients using cell surface markers found
on cancer cells such as CD44 and epithelial specific antigen.


Inclusion Criteria:

Inclusion Criteria:

Inclusion Criteria (Cases):

1. Advanced stage (IIIB with malignant effusion or IV) histologically or cytologically
confirmed NSCLC

2. Patients must be newly diagnosed (untreated) or have evidence of disease progression
at the time of sample collection

3. ability to sign informed consent

4. at least 18 years of age

Inclusion Criteria (Controls):

1. no known prior or active malignancy

2. ability to sign informed consent

3. at least 18 years of age Exclusion Criteria:1. history of any other cancer other than
non-melanoma skin cancer within the last 5 years

Exclusion Criteria:1. history of any other cancer other than non-melanoma skin cancer
within the last 5 years

2. pregnant women

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

to determine whether we can identify human lung cancer tumor cells in the peripheral blood of lung cancer patients using cell surface markers found on cancer cells.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Heather A. Wakelee

Investigator Role:

Principal Investigator

Investigator Affiliation:

Stanford University

Authority:

United States: Food and Drug Administration

Study ID:

LUN0017

NCT ID:

NCT00568282

Start Date:

February 2007

Completion Date:

July 2014

Related Keywords:

  • Lung Cancer
  • Lung Neoplasms
  • Neoplastic Cells, Circulating

Name

Location

Stanford University School of MedicineStanford, California  94305-5317